Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0PV9N
|
|||
| Drug Name |
GC4419
|
|||
| Synonyms |
Avasopasem manganese; UNII-EY1WA413UL; EY1WA413UL; Avasopasem manganese [USAN]; SC-72325A; M-40419; 435327-40-5; Manganese, dichloro((4aS,13aS,17aS,21aS)-1,2,3,4,4a,5,6,12,13,13a,14,15,16,17,17a,18,19,20,21,21a-eicosahydro-7,11-nitrilo-7H-dibenzo(b,H)-5,13,18,21-tetraazacycloheptadecine-kappaN5,kappaN13,kappaN18,kappaN21,kappaN22)-, (pb-7-11-2344'3')-
Click to Show/Hide
|
|||
| Indication | Oral mucositis [ICD-11: DA01.11; ICD-10: K12.3; ICD-9: 528] | Phase 2 | [1] | |
| Pancreatic cancer [ICD-11: 2C10] | Phase 1/2 | [2] | ||
| Company |
Galera Therapeutics Malvern, PA
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H35Cl2MnN5
|
|||
| Canonical SMILES |
C1CCC2C(C1)NCCNC3CCCCC3NCC4=CC=CC(=N4)CN2.[Cl-].[Cl-].[Mn+2]
|
|||
| InChI |
1S/C21H35N5.2ClH.Mn/c1-3-10-20-18(8-1)22-12-13-23-19-9-2-4-11-21(19)25-15-17-7-5-6-16(26-17)14-24-20;;;/h5-7,18-25H,1-4,8-15H2;2*1H;/q;;;+2/p-2/t18-,19-,20-,21-;;;/m0.../s1
|
|||
| InChIKey |
WXEMWBBXVXHEPU-NDOCQCNASA-L
|
|||
| CAS Number |
CAS 435327-40-5
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.